Bruce Morland

7.8k citations

95 papers · 2.8k indexed · h-index 30

Impact in

Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Oncology top 5%
- Pancreatic and Hepatic Oncology Research

Papers in

Hepatology 18
- Hepatocellular Carcinoma Treatment and Prognosis 17
Neurology 19
- Neuroblastoma Research and Treatments 17

Co-authors: Piotr Czauderna Rudolf Maibach Giorgio Perilongo Derek Roebuck Birgit Geoerger Gilles Vassal Penelope Brock Daniël C. Aronson
Journals: Journal of Clinical Oncology (13 papers)European Journal of Cancer (9 papers)British Journal of Cancer (5 papers)Pediatric Blood & Cancer (5 papers)Pediatric Transplantation (3 papers)
Partner nations: United Kingdom France United States

In The Last Decade

Bruce Morland

91 papers receiving 2.7k citations

Peers

Countries citing papers authored by Bruce Morland

Since Specialization

Citations

This map shows the geographic impact of Bruce Morland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Morland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Morland more than expected).

Fields of papers citing papers by Bruce Morland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Morland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Morland. The network helps show where Bruce Morland may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bruce Morland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce Morland Line = papers co-authored together Bruce Morland links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Liver resection extended to adjacent structures for advanced hepatoblastoma – a 25 year tertiary hepatobiliary and transplant center experience HPB ·Víola B. Weeda, Khalid Sharif, Girish Gupte, 中岡望, Евгений Евгеньевич Мартыненко, P. J. McKiernan, James A. Bennett, Muftichatul Daroyah, Evelyn Ong, В. П. Чижков, Bruce Morland, Alexandr F. Seliverstov	2025	0
2	Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy British Journal of Ophthalmology ·Andrew W. Stacey, Mai Tsukikawa, Ido Didi Fabian, Karger, Helen Jenkinson, Dessy Amelia, Martina Čuljak, Bruce Morland, John R. Ainsworth, M. Ashwin Reddy, Manoj Parulekar, Mandeep S. Sagoo	2020	1
3	Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC) Bone Marrow Transplantation ·Bruce Morland, Tomáš Kepák, Sandro Dallorso, Julián Sevilla, R. E. Benson, Roberto Luksch, Isaac Yaniv, Peter Bader, Jochen Rößler, Gianni Bisogno, Britta Maecker‐Kolhoff, Peter Lang, C. Michel Zwaan, David Sumerauer, Gergely Kriván, John Bernard, Qianying Liu, Chen Chan-juan, Franco Locatelli	2020	19
4	Early phase clinical trials of anticancer agents in children and adolescents — an ITCC perspective Nature Reviews Clinical Oncology ·Lucas Moreno, Andrew D.J. Pearson, Xavier Paolettí, Irène Jiménez, Birgit Geoerger, Pamela Kearns, C. Michel Zwaan, François Doz, André Baruchel, Josef Vormoor, Michela Casanova, Stefan M. Pfister, Bruce Morland, Gilles Vassal	2017	52
5	From class waivers to precision medicine in paediatric oncology The Lancet Oncology ·Andrew D.J. Pearson, Stefan M. Pfister, André Baruchel, Jean‐Pierre Bourquin, Michela Casanova, Louis Chesler, François Doz, Angelika Eggert, Birgit Geoerger, David Jones, Pamela Kearns, Jan J. Molenaar, Bruce Morland, Gudrun Schleiermacher, Johannes H. Schulte, Josef Vormoor, Lynley V. Marshall, C. Michel Zwaan, Gilles Vassal	2017	36
6	A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study Clinical Cancer Research ·Lucas Moreno, Lynley V. Marshall, Andrew D.J. Pearson, Bruce Morland, Martin Elliott, Quentin Campbell‐Hewson, Guy Makin, Sarah Halford, Gary D Acton, Philip Ross, 李翠霞, Victoria Lock, Ana Isabel Enríquez Rodríguez, John F. Lyons, Alan V. Boddy, E Badian, Murray Yule, Darren Hargrave	2014	39
7	The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials Journal of Indian Association of Pediatric Surgeons ·A. Stancu, Piotr Czauderna, Rudolf Maibach, Giorgio Perilongo, Bruce Morland	2014	70
8	Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study The Lancet Oncology ·József Zsíros, Laurence Brugières, Penelope Brock, Derek Roebuck, Rudolf Maibach, Arthur Zimmermann, Margaret Childs, Danièle Pariente, Véronique Laithier, Jean-Bernard Otte, Sophie Branchereau, Daniël C. Aronson, Arun Rangaswami, Milind Ronghe, Michela Casanova, Michael Sullivan, Bruce Morland, Piotr Czauderna, Giorgio Perilongo	2013	217
9	New drug development in childhood cancer Current Opinion in Pediatrics ·Pamela Kearns, Bruce Morland	2013	3
10	Prognostic stratification for children with hepatoblastoma: The SIOPEL experience European Journal of Cancer ·Rudolf Maibach, Derek Roebuck, Laurence Brugières, Michael Capra, Penelope Brock, Patrizia Dall’Igna, Jean-Bernard Otté, Beatriz de Camargo, József Zsíros, Arthur Zimmermann, Daniël C. Aronson, Margaret Childs, Marcelo Scopinaro, Bruce Morland, J. Plaschkes, Piotr Czauderna, Giorgio Perilongo	2012	115
11	Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma – A phase II trial of the childhood liver tumour strategy group (SIOPEL) European Journal of Cancer ·József Zsíros, Laurence Brugières, Penelope Brock, Derek Roebuck, Rudolf Maibach, M A Child, Bruce Morland, Michela Casanova, Danièle Pariente, Ingrid Hauss, Beatriz de Camargo, Milind Ronghe, Arthur Zimmermann, J. Plaschkes, Piotr Czauderna, Giorgio Perilongo	2012	40
12	Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone – The results of the United Kingdom HD3 national cohort trial European Journal of Cancer ·Ananth Shankar, Aspácia Domingos Madeira, Helena Benatt do Nascimento Alves, Bruce Morland, Keith McCarthy, Martin Hewitt	2011	9
13	The role of the ‘innovative therapies for children with cancer’ (ITCC) European consortium Cancer Treatment Reviews ·C. Michel Zwaan, Pamela Kearns, Huib N. Caron, Arnauld Verschuur, Riccardo Riccardi, Joachim Boos, François Doz, Birgit Geoerger, Bruce Morland, Gilles Vassal	2010	46
14	Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma New England Journal of Medicine ·Giorgio Perilongo, Rudolf Maibach, Shilham Astif Syarifuddin, Laurence Brugières, Penelope Brock, Bruce Morland, Beatriz de Camargo, József Zsíros, Derek Roebuck, Arthur Zimmermann, Daniël C. Aronson, Margaret Childs, Eva Widing, Véronique Laithier, J. Plaschkes, Jon Pritchard, 김유순, Gordon A. MacKinlay, Piotr Czauderna	2009	205
15	Commentary on hepatoblastoma minisymposium Pediatric Radiology ·Bruce Morland	2006	1
16	Anaesthetic outcome and predictive risk factors in children with mediastinal tumours Pediatric Blood & Cancer ·Shu‐Kay Ng, James Bennett, Maroš Maroš Volovár, Paul Davies, Bruce Morland	2005	32
17	Paediatric malignant tumours of the gastrointestinal tract in the West Midlands, UK, 1957–2000: A large population based survey Pediatric Blood & Cancer ·Carmeta Albarus, Vaibhavi Mhatre, Peter Davies, Bruce Morland	2004	1
18	Paraganglioma of the Vagina: The First Report of a Rare Tumor in a Child Pediatric Hematology and Oncology ·Vaibhavi Mhatre, F. Raafat, Bruce Morland	1998	11
19	Decline in incidence of medulloblastoma in children Cancer ·Bruce Morland, Vaibhavi Mhatre, Gakuto Tani, Andrew D.J. Pearson, James A. R. Nicoll, Hugh B. Coakham, A Oakhill, LI Ran-qi, Nicholas K. Foreman	1995	3
20	Cutaneous squamous cell carcinoma following treatment for acute lymphoblastic leukaemia Medical and Pediatric Oncology ·Bruce Morland, Takaaki Sasaki	1993	2

About Bruce Morland

Bruce Morland is a scholar working on Hepatology, Neurology, Oncology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Neuroblastoma Research and Treatments (17 papers), Childhood Cancer Survivors' Quality of Life (14 papers), Pancreatic and Hepatic Oncology Research (10 papers), Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (8 papers), Sarcoma Diagnosis and Treatment (8 papers) and Renal and related cancers (7 papers). The work is most often cited by research in Hepatology (799 citations), Oncology (963 citations), Neurology (471 citations), Cancer Research (329 citations) and Pulmonary and Respiratory Medicine (581 citations). Bruce Morland has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Piotr Czauderna, Rudolf Maibach, Giorgio Perilongo, Derek Roebuck, Birgit Geoerger, Gilles Vassal, Penelope Brock, Daniël C. Aronson, Laurence Brugières and Margaret Childs. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Pediatric Blood & Cancer and Pediatric Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact